Pfizer Inc.’s Lyrica Fails in Diabetes Trial, Halts HIV Study

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE - News) announced today that it has stopped a Phase 3 clinical trial of Lyrica (pregabalin) in patients with neuropathic pain associated with HIV neu…
Read the full story: BioSpace.com Featured News